Aurinia Pharmaceuticals Inc (AUPH) — Free Cash Flow Generation Index

Latest as of June 2026: 1.62x

Aurinia Pharmaceuticals Inc (AUPH) has a Free Cash Flow Generation Index of 1.62x as of June 2026. Free cash flow of $85.09 Million represents 2% of operating cash flow ($52.57 Million). Explore AUPH capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.62x
Free Cash Flow / Operating CF

Free Cash Flow

$85.09 Million
USD

Operating Cash Flow

$52.57 Million
USD

Capital Expenditures

$39.00K
USD

Aurinia Pharmaceuticals Inc Free Cash Flow Generation Index (2024–2025)

Historical FCF Generation Index trend for Aurinia Pharmaceuticals Inc across 2 annual periods. For the full cash flow conversion analysis, see Aurinia Pharmaceuticals Inc operating cash flow efficiency.

Annual Free Cash Flow Generation for Aurinia Pharmaceuticals Inc (2024–2025)

Year-by-year Free Cash Flow Generation Index for Aurinia Pharmaceuticals Inc. Check Aurinia Pharmaceuticals Inc (AUPH) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 1.00x $135.41 Million $135.66 Million $252.00K ▲ +0.5%
2024 0.99x $44.11 Million $44.39 Million $281.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).